Eledon Pharmaceuticals, Inc. (ELDN) Tops Q3 EPS by 8c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q3 EPS of ($0.35), $0.08 better than the analyst estimate of ($0.43).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• MaxLinear (MXL) Tops Q2 EPS by 2c; Offers Guidance
• Business First Bancshares, Inc. (BFST) Tops Q2 EPS by 1c